Our findings suggest that the AR phenotype may represent a unique vasculoinflammatory biological signature accompanying dopaminergic neurodegeneration, a peripheral reflection of the platelet-inflammatory axis, and thus offer an innovative pathophysiological window for biomarker-based differentiation of PD subtypes. This evidence concerns the gene AR and Parkinson disease.